{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:33:17Z","timestamp":1764603197729},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T00:00:00Z","timestamp":1371772800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1038\/cgt.2013.31","type":"journal-article","created":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T10:17:18Z","timestamp":1371809838000},"page":"421-427","source":"Crossref","is-referenced-by-count":24,"title":["Additive antileukemia effects by GFI1B- and BCR\u2013ABL-specific siRNA in advanced phase chronic myeloid leukemic cells"],"prefix":"10.1038","volume":"20","author":[{"given":"M","family":"Koldehoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J L","family":"Zakrzewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D W","family":"Beelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A H","family":"Elmaagacli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,21]]},"reference":[{"key":"BFcgt201331_CR1","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MW Deininger","year":"2000","unstructured":"Deininger MW, Goldman JM, Melo JV . The molecular biology of chronic myeloid leukemia. Blood 2000; 96: 3343\u20133356.","journal-title":"Blood"},{"key":"BFcgt201331_CR2","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMra020777","volume":"349","author":"JM Goldmann","year":"2003","unstructured":"Goldmann JM, Melo JV . Chronic myeloid leukemia - advances in biology and new approaches to treatment. N Engl J Med 2003; 349: 1451\u20131461.","journal-title":"N Engl J Med"},{"key":"BFcgt201331_CR3","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1073\/pnas.0510423103","volume":"103","author":"JP Radich","year":"2006","unstructured":"Radich JP, Dai H, Mao M, Oehler V, Schelter J, Druker B et al. Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci USA 2006; 103: 2794\u20132799.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201331_CR4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1432-0436.2008.00270.x","volume":"76","author":"M Simanovsky","year":"2008","unstructured":"Simanovsky M, Berlinsky S, Sinai P, Leiba M, Nagler A, Galski H . Phenotypic and gene expression diversity of malignant cells in human blast crisis chronic myeloid leukemia. Differentiation 2008; 76: 908\u2013922.","journal-title":"Differentiation"},{"key":"BFcgt201331_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1517\/14796694.1.1.103","volume":"1","author":"H Lage","year":"2005","unstructured":"Lage H . Potential applications of RNA interference technology in the treatment of cancer. Future Oncol 2005; 1: 103\u2013113.","journal-title":"Future Oncol"},{"key":"BFcgt201331_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/35078107","volume":"411","author":"SM Elbashir","year":"2001","unstructured":"Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T . Duplexes of 21- nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494\u2013498.","journal-title":"Nature"},{"key":"BFcgt201331_CR7","first-page":"326","volume":"90","author":"AH Elmaagacli","year":"2005","unstructured":"Elmaagacli AH, Koldehoff M, Peceny R, Klein-Hitpass L, Ottinger H, Beelen DW et al. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells. Haematologica 2005; 90: 326\u2013334.","journal-title":"Haematologica"},{"key":"BFcgt201331_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3324\/haematol.2009.016063","volume":"95","author":"M Koldehoff","year":"2010","unstructured":"Koldehoff M, Kordelas L, Beelen DW, Elmaagacli AH . Small interfering RNA against BCR-ABL transcripts sensitize mutated T315I cells to nilotinib. Haematologica 2010; 95: 388\u2013397.","journal-title":"Haematologica"},{"key":"BFcgt201331_CR9","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1128\/MCB.18.5.2462","volume":"18","author":"B Tong","year":"1998","unstructured":"Tong B, Grimes HL, Ty Yang, Bear SE, Qin Z, Du K et al. The GFI1B proto-oncoprotein represses p21WAF1 and inhibits myloid cell differentation. Mol Cell Bio 1998; 18: 2462\u20132473.","journal-title":"Mol Cell Bio"},{"key":"BFcgt201331_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1006\/geno.1998.5601","volume":"54","author":"B Rodel","year":"1998","unstructured":"Rodel B, Wagner T, Zornig M, Niessing J, Moroy T . The human homologue (GFI1B) of the chicken GFI gene maps to chromosome 9q34.13-A locus frequently altered in hematopoietic diseases. Genomics 1998; 54: 580\u2013582.","journal-title":"Genomics"},{"key":"BFcgt201331_CR11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1365-2141.2006.06407.x","volume":"136","author":"AH Elmaagacli","year":"2007","unstructured":"Elmaagacli AH, Koldehoff M, Zakrzewski JL, Steckel NK, Ottinger H, Beelen DW . Growth factor-independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate. Br J Haematol 2007; 136: 212\u2013219.","journal-title":"Br J Haematol"},{"key":"BFcgt201331_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s12185-009-0286-5","volume":"89","author":"L Vassen","year":"2009","unstructured":"Vassen L, Khandanpour C, Ebeling P, van der Reijden BA, Jansen JH, Mahlmann S et al. Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia. Int J Hematol 2009; 89: 422\u2013430.","journal-title":"Int J Hematol"},{"key":"BFcgt201331_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12185-007-0013-z","volume":"87","author":"M Koldehoff","year":"2008","unstructured":"Koldehoff M, Zakrzewski JL, Klein-Hitpass L, Beelen DW, Elmaagacli AH . Gene profiling of growth factor independence 1B gene (GFI1B) in leukemic cells. Int J Hematol 2008; 87: 39\u201347.","journal-title":"Int J Hematol"},{"key":"BFcgt201331_CR14","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1046\/j.1365-2141.2001.02858.x","volume":"113","author":"AH Elmaagacli","year":"2001","unstructured":"Elmaagacli AH, Freist A, Hahn M, Opalka B, Seeber S, Schaefer SW et al. Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method. Br J Haematol 2001; 113: 1072\u20131075.","journal-title":"Br J Haematol"},{"key":"BFcgt201331_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0002-9440(10)63985-5","volume":"158","author":"K Specht","year":"2001","unstructured":"Specht K, Richter T, Muller U, Walch A, Werner M, Hofler H . Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol 2001; 158: 419\u2013429.","journal-title":"Am J Pathol"},{"key":"BFcgt201331_CR16","first-page":"569","volume":"87","author":"ML Larramendy","year":"2002","unstructured":"Larramendy ML, Niini T, Elonen E, Nagy B, Ollila J, Vihinen M et al. Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis. Haematologica 2002; 87: 569\u2013577.","journal-title":"Haematologica"},{"key":"BFcgt201331_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1532\/IJH97.E0624","volume":"86","author":"M Kourti","year":"2007","unstructured":"Kourti M, Vavatsi N, Gombakis N, Sidi V, Tzimagiorgis G, Papageorgiou T et al. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia. Int J Hematol 2007; 86: 166\u2013173.","journal-title":"Int J Hematol"},{"key":"BFcgt201331_CR18","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1182\/blood-2002-06-1685","volume":"101","author":"M Scherr","year":"2003","unstructured":"Scherr M, Battmer K, Winkler T, Heidenreich O, Ganser A, Eder M . Specific inhibition of BCR-ABL gene expression by small interfering RNA. Blood 2003; 101: 1566\u20131569.","journal-title":"Blood"},{"key":"BFcgt201331_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/430161a","volume":"430","author":"CD Novina","year":"2004","unstructured":"Novina CD, Sharp PA . The RNAi revolution. Nature 2004; 430: 161\u2013164.","journal-title":"Nature"},{"key":"BFcgt201331_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10238-007-0125-z","volume":"7","author":"M Koldehoff","year":"2007","unstructured":"Koldehoff M, Steckel NK, Beelen DW, Elmaagacli AH . Therapeutic application of small interfering RNA directed against BCR-ABL transcripts to a patient with imatinib-resistant chronic myeloid leukaemia. Clin Exp Med 2007; 7: 47\u201355.","journal-title":"Clin Exp Med"},{"key":"BFcgt201331_CR21","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1182\/blood-2002-12-3899","volume":"102","author":"L Wohlbold","year":"2003","unstructured":"Wohlbold L, van der Kuip H, Miething C, Vornlocher HP, Knabbe C, Duyster J et al. Inhibition of BCR-ABL gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood 2003; 102: 2236\u20132269.","journal-title":"Blood"},{"key":"BFcgt201331_CR22","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.1038\/sj.onc.1205653","volume":"21","author":"M Wilda","year":"2002","unstructured":"Wilda M, Fuchs U, W\u00f6ssmann W, Borkhardt A . Killing of leukemic cells with a BCR\/ABL fusion gene by RNA interference. Oncogene 2002; 21: 5716\u20135724.","journal-title":"Oncogene"},{"key":"BFcgt201331_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11033-006-9006-x","volume":"34","author":"M Merkerova","year":"2007","unstructured":"Merkerova M, Klamova H, Brdicka R, Bruchova H . Targeting of gene expression by siRNA in CML primary cells. Mol Biol Rep 2007; 34: 27\u201333.","journal-title":"Mol Biol Rep"},{"key":"BFcgt201331_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2141.2005.05468.x","volume":"129","author":"JM Withey","year":"2005","unstructured":"Withey JM, Marley SB, Kaeda J, Harvey AJ, Crompton MR, Gordon MY . Targeting primary human leukaemia cells with RNA interference: BCR-ABL targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells. Br J Haematol 2005; 129: 377\u2013380.","journal-title":"Br J Haematol"},{"key":"BFcgt201331_CR25","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nmeth911","volume":"3","author":"Y Pei","year":"2006","unstructured":"Pei Y, Tuschl T . On the art of identifying effective and specific siRNAs. Nat Methods 2006; 3: 670\u2013676.","journal-title":"Nat Methods"},{"key":"BFcgt201331_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of BCR-ABL positive cells. Nat Med 1996; 2: 561\u2013566.","journal-title":"Nat Med"},{"key":"BFcgt201331_CR27","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1172\/JCI41246","volume":"120","author":"D Perrotti","year":"2010","unstructured":"Perrotti D, Jamieson C, Goldman J, Skorski T . Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest 2010; 120: 2254\u20132264.","journal-title":"J Clin Invest"},{"key":"BFcgt201331_CR28","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1038\/sj.onc.1206085","volume":"21","author":"D Perrotti","year":"2002","unstructured":"Perrotti D, Calabretta B . Post-transcriptional mechanisms in BCR\/ABL leukemogenesis: role of shuttling RNA-binding proteins. Oncogene 2002; 21: 8577\u20138583.","journal-title":"Oncogene"},{"key":"BFcgt201331_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/156800911793743619","volume":"11","author":"H Rumpold","year":"2011","unstructured":"Rumpold H, Webersinke G . Molecular pathogenesis of Philadelphia-positive chronic myeloid leukemia - is it all BCR-ABL? Curr Cancer Drug Targets 2011; 11: 3\u201319.","journal-title":"Curr Cancer Drug Targets"},{"key":"BFcgt201331_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1084\/jem.20110645","volume":"209","author":"D Schulz","year":"2012","unstructured":"Schulz D, Vassen L, Chow KT, McWhirter SM, Amin RH, M\u00f6r\u00f6y T et al. Gfi1b negatively regulates Rag expression directly and via the repression of FoxO1. J Exp Med 2012; 209: 187\u2013199.","journal-title":"J Exp Med"},{"key":"BFcgt201331_CR31","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/cncr.20468","volume":"101","author":"H Ohba","year":"2004","unstructured":"Ohba H, Zhelev Z, Bakalova R, Ewis A, Omori T, Ishikawa M et al. Inhibition of BCR-ABL and\/or c-abl gene expression by small interfering, double-stranded RNAs: cross-talk with cell proliferation factors and other oncogenes. Cancer 2004; 101: 1390\u20131403.","journal-title":"Cancer"},{"key":"BFcgt201331_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11899-012-0121-6","volume":"7","author":"LA Crews","year":"2012","unstructured":"Crews LA, Jamieson CH . Chronic myeloid leukemia stem cell biology. Curr Hematol Malig Rep 2012; 7: 125\u2013132.","journal-title":"Curr Hematol Malig Rep"},{"key":"BFcgt201331_CR33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1158\/1541-7786.MCR-10-0356","volume":"9","author":"M Albajar","year":"2011","unstructured":"Albajar M, G\u00f3mez-Casares MT, Llorca J, Mauleon I, Vaqu\u00e9 JP, Acosta JC et al. MYC in chronic myeloid leukemia: induction of aberrant DNA synthesis and association with poor response to imatinib. Mol Cancer Res 2011; 9: 564\u2013576.","journal-title":"Mol Cancer Res"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cgt201331.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cgt201331","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cgt201331.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:14:04Z","timestamp":1684415644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,21]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["BFcgt201331"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2013.31","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"type":"print","value":"0929-1903"},{"type":"electronic","value":"1476-5500"}],"subject":[],"published":{"date-parts":[[2013,6,21]]}}}